Quantification and Visualization of the Transport of Octreotide, a Somatostatin Analogue, Across Monolayers of Cerebrovascular Endothelial Cells
- 1 January 1994
- journal article
- Published by Springer Science and Business Media LLC in Pharmaceutical Research
- Vol. 11 (3), 442-448
- https://doi.org/10.1023/a:1018929508018
Abstract
Confocal laser scanning microscopy (CLSM) was used to quantify and visualize the transport of the octapeptide and somatostatin analogue, octreotide (SMS 201-995, Sandostatin), across monolayers of bovine cerebrovascular endothelial cells, an in vitro model of the blood–brain barrier. The concentrations of octreotide and its conjugates in the cell culture medium were determined by radioimmunoassay (RIA). Two fluorescent conjugates of octreotide (FITC- and NBD-octreotide) were used to obtain CLSM images. The peptides did not undergo significant degradation in the presence of brain endothelial cell monolayers. The transport rate of octreotide expressed as clearance (Cl) and endothelial permeability (Pe) did not depend on either the initial concentration (between 10 nM and 1 µM) or the site of administration (luminal or abluminal side of the mono-layer), indicating the absence of saturable and/or asymmetrical transport mechanisms. The Pe of octreotide and that of the paracellular permeability marker fluorescein correlated well. Although the conjugates are more lipophilic than octreotide itself, they exhibited lower Cl and Pe, values probably because of their larger molecular size. On the CLSM images, FITC-octreotide was present only in the intercellular space, while the cells did not exhibit detectable fluorescence. Transport studies and CLSM images suggest that octreotide passes the endothelial monolayer primarily via the paracellular route without significant contribution of carrier-mediated transport.Keywords
This publication has 15 references indexed in Scilit:
- Intestinal absorption of the octapeptide SMS 201–995 visualized by fluorescence derivatizationGastroenterology, 1991
- Delivering Peptides to the Central Nervous System: Dilemmas and StrategiesPharmaceutical Research, 1991
- Future medical prospects for SandostatinMetabolism, 1990
- Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin.Proceedings of the National Academy of Sciences of the United States of America, 1990
- Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier.1990
- An Easier, Reproducible, and Mass‐Production Method to Study the Blood–Brain Barrier In VitroJournal of Neurochemistry, 1990
- The Use of Cultured Epithelial and Endothelial Cells for Drug Transport and Metabolism StudiesPharmaceutical Research, 1990
- Disposition of sandostatin, a new synthetic somatostatin analogue, in rats.1989
- OctreotideDrugs, 1989
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982